Alutard Sq

Alutard SQ is a subcutaneous allergy treatment containing Dermatophagoides Pteronyssinus and Aluminium. It is designed to help manage allergic reactions by building tolerance to specific allergens. This medication is manufactured by Alk-Abello A/S in the EU.

Alutard SQ is primarily used for the treatment of allergies caused by house dust mites. It works by gradually introducing small amounts of the allergen into the body, helping to reduce the severity of allergic reactions over time. This process is known as allergen immunotherapy and is often recommended for individuals who experience persistent symptoms despite other treatments.

Common effects of Alutard SQ may include localized reactions at the injection site, such as redness, swelling, or itching. Some individuals may also experience mild systemic reactions like sneezing, nasal congestion, or itchy eyes. These effects are generally temporary and should subside as the body adjusts to the treatment.

Alutard SQ should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any known allergies or medical conditions before starting treatment. Always follow the prescribed dosage and administration schedule to minimize the risk of adverse reactions.

Alutard SQ may interact with certain medications, including beta-blockers and antihistamines. It is advisable to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, alcohol consumption should be moderated during treatment to prevent any unwanted effects.